George Christopher Eliades

This profile gathers the share dealings of George Christopher Eliades in Oyster Point Pharma, Inc., where the filings describe the role as board member. Over a trading history stretching from 7 June 2021 to 3 January 2023, the count stands at 3 filings.

None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.

Most recently, on 4 January 2023, the filings show a transaction in Oyster Point Pharma, Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. Section 16 rules allow two business days to file each Form 4. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.